Augmedix Inc
NASDAQ:AUGX
Intrinsic Value
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. [ Read More ]
The intrinsic value of one
AUGX
stock under the Base Case scenario is
2.25
USD.
Compared to the current market price of 5.15 USD,
Augmedix Inc
is
Overvalued by 56%.
Whether you're assessing long-term stability or short-term opportunities, Historical Valuation serves as a vital tool to enhance your investment approach, enabling you to make more informed investment decisions.
Sign up
to access Augmedix Inc's intrinsic value history.
No restrictions, no limits.
All stocks, all tools.
Look for stocks that have been historically overvalued but are now trading below their intrinsic value.
Avoid stocks that are always undervalued and never reach their intrinsic value.
Find stocks that have historically corrected quickly from being undervalued to reaching their intrinsic value.
There are two methods to calculate the Intrinsic Value of a stock: DCF Valuation and Relative Valuation. We take the average of these two methods to estimate the intrinsic value as accurately as possible. You can see the Intrinsic Value of a stock at the top of this page.
DCF Value
Discounted Cash Flow
Fundamental Analysis
Balance Sheet Decomposition
Augmedix Inc
| Current Assets | 36.1m |
| Cash & Short-Term Investments | 24.6m |
| Receivables | 9.4m |
| Other Current Assets | 2.1m |
| Non-Current Assets | 7.8m |
| PP&E | 6.2m |
| Other Non-Current Assets | 1.5m |
| Current Liabilities | 21.3m |
| Accounts Payable | 1.6m |
| Accrued Liabilities | 6m |
| Other Current Liabilities | 13.7m |
| Non-Current Liabilities | 18.6m |
| Long-Term Debt | 14.9m |
| Other Non-Current Liabilities | 3.7m |
AUGX Profitability Score
Profitability Due Diligence
Augmedix Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Score
Augmedix Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
AUGX Solvency Score
Solvency Due Diligence
Augmedix Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Score
Augmedix Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AUGX Price Targets Summary
Augmedix Inc
According to Wall Street analysts, the average 1-year price target for
AUGX
is 6.76 USD
with a low forecast of 6.06 USD and a high forecast of 8.4 USD.
Ownership
AUGX Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
AUGX Price
Augmedix Inc
| Average Annual Return | -35.2% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -86% |
| Market Capitalization | 210m USD |
| Shares Outstanding | 40 675 500 |
| Percentage of Shares Shorted | 1.35% |
Company Profile
Augmedix Inc
Country
Industry
Market Cap
Dividend Yield
Description
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 706 full-time employees. The company went IPO on 2021-03-04. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and provides a suite of related services. The medical note is generated using Augmedix’s proprietary platform, which incorporates structured data models, automatic speech recognition and natural language processing and is overseen by trained medical documentation specialists (MDS). Augmedix provides service from approximately nine MDS operations centers across four countries: the United States, Bangladesh, India and Sri Lanka.
Contact
IPO
Employees
Officers
The intrinsic value of one
AUGX
stock under the Base Case scenario is
2.25
USD.
Compared to the current market price of 5.15 USD,
Augmedix Inc
is
Overvalued by 56%.
Sensibly Priced Quality
Significantly Undervalued
Magic Formula
High Growth
